John S. McBride

CIK 1618251 · Chief Operating Officer · last filed 2026-01-16

John S. McBride is a Chief Operating Officer who has filed 13 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for ELDN, was dated Jan 16, 2026. Across all open-market trades the lifetime net is −$315.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $12.2K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$12.2K

Companies

3

Total Filings

13

Lifetime Open-Market Net

-$315.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ELDN Director 3,430 $3.57 $12.2K $0 5 2026-01-16
Eledon Pharmaceuticals, Inc. (NVUS) Delisted Director $0 4 2020-09-15
Eledon Pharmaceuticals, Inc. (TKAI) Delisted Chief Operating Officer 0 -$315.2K 4 2015-12-17

Recent Filings

13 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-01-16 ELDN Exer (M) +3,430 $0 EDGAR
2025-01-13 ELDN Grant (A) $0 EDGAR
2023-05-02 ELDN Grant (A) $0 EDGAR
2023-02-02 ELDN Grant (A) $0 EDGAR
2022-02-02 ELDN Grant (A) $0 EDGAR
2020-09-15 Eledon Pharmaceuticals, Inc. (NVUS) Delisted Grant (A) $0 EDGAR
2019-07-15 Eledon Pharmaceuticals, Inc. (NVUS) Delisted Grant (A) $0 EDGAR
2018-06-14 Eledon Pharmaceuticals, Inc. (NVUS) Delisted Grant (A) $0 EDGAR
2017-07-05 Eledon Pharmaceuticals, Inc. (NVUS) Delisted Grant (A) $0 EDGAR
2015-12-17 Eledon Pharmaceuticals, Inc. (TKAI) Delisted Grant (A) $0 EDGAR
Showing 110 of 13
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.